{
  "id": "604915581cb411341a00016a",
  "type": "yesno",
  "question": "Is YKL-40 used as a biomarker for Alzheimer's disease?",
  "ideal_answer": "Yes,\ncerebrospinal fluid (CSF) YKL-40 levels were reported to be a promising candidate biomarker of glial inflammation in Alzheimer's disease (AD).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31668967",
    "http://www.ncbi.nlm.nih.gov/pubmed/31794792",
    "http://www.ncbi.nlm.nih.gov/pubmed/32045356"
  ],
  "snippets": [
    {
      "text": "Recently, cerebrospinal fluid (CSF) YKL-40 levels were reported to be a promising candidate biomarker of glial inflammation in Alzheimer's disease (AD). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31794792",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disease groups differed between them except AD versus FTD for YKL-40. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31668967",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "YKL-40 appears to be a more reliable biomarker in neurological diseases than NSE.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32045356",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}